Brennan et al. [8] and Kurzen et al. [9] showed that DSG2 was more highly expressed in skin squamous cell carcinoma and basal cell carcinoma and that the positive rate was higher in high-risk patients. This evidence concerns the gene DSG2 and skin squamous cell carcinoma.